Reports for HYDROCHLOROTHIAZIDE
Ingredient
HYDROCHLOROTHIAZIDE
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| SANDOZ IRBESARTAN HCT | 12.5MG 300MG | TABLET | Resolved | 2019-04-01 | 2020-06-22 | 80194 |
| SANDOZ IRBESARTAN HCT | 300MG 12.5MG | TABLET | Resolved | 2020-09-21 | 2020-10-27 | 124609 |
| SANDOZ IRBESARTAN HCT | 300MG 12.5MG | TABLET | Resolved | 2020-09-21 | 2020-10-27 | 124612 |
| SANDOZ IRBESARTAN HCT | 12.5MG 300MG | TABLET | Resolved | 2023-03-06 | 2023-03-28 | 186285 |
| SANDOZ IRBESARTAN HCT | 12.5MG 300MG | TABLET | Resolved | 2023-08-07 | 2023-08-15 | 201264 |
| SANDOZ IRBESARTAN HCT | 12.5MG 300MG | TABLET | Resolved | 2023-12-04 | 2024-01-18 | 212445 |
| SANDOZ IRBESARTAN HCT | 12.5MG 300MG | TABLET | Resolved | 2024-09-16 | 2024-10-15 | 237750 |
| SANDOZ IRBESARTAN HCT | 12.5MG 300MG | TABLET | Resolved | 2024-10-28 | 2024-12-11 | 241400 |
| SANDOZ IRBESARTAN HCT | 12.5MG 300MG | TABLET | Resolved | 2025-01-27 | 2025-06-03 | 248642 |
| SANDOZ IRBESARTAN HCT | 25MG 300MG | TABLET | Resolved | 2017-03-14 | 2017-05-08 | 2705 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255830 |
| TEVA-VALSARTAN/HCTZ | 25MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255833 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256140 |
| TEVA-VALSARTAN/HCTZ | 25MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256143 |
| TEVETEN PLUS | 12.5MG 600MG | TABLET | Discontinued | 2024-12-10 | 2024-12-10 | 245261 |
| VALSARTAN HCT | 25MG 320MG | TABLET | Discontinued | 2019-09-18 | 2020-01-09 | 94211 |